Morphometric evaluation of the effect of methenolone enanthate on humeral development in adolescent rats

Basit Öğe Kaydı
dc.contributor.authorBozkurt I.
dc.contributor.authorOzdemir M.
dc.contributor.authorPepe K.
dc.contributor.authorOzdemir O.
dc.contributor.authorCoskun A.
dc.date.accessioned2020-03-26T18:22:17Z
dc.date.available2020-03-26T18:22:17Z
dc.date.issued2011
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractThe effect of methenolone enanthate (ME), one of the anabolic-androgenic steroids (AAS), used as a muscle amplifier and for doping by athletes, on the humerus bone development of adolescent male and female rats has been researched in this study. Three different groups for each male and female rat, including 8 rats of each, (ME, V, C) were formed and a total of 48 rats were used. The subject groups were given 0.5 mg/kg methenolone enanthate (Primobolan® Depot, Bayer) diluted in peanut oil, 0.5 ml; all animals received five intraperitoneal injections weekly for four weeks. The rats were euthanized at the end of the four weeks and both humerus dissected and macerated. The length, corpus thickness, compact bone thickness and medulla canal diameter were measured with calipers and the average of each was noted. The effect of ME administration on humerus length and corpus femoris thickness was negative in male animals but positive in females and was determined to be statistically significant (p<0.05) in both cases. There was no treatment-related difference in compact bone thickness and medulla diameter (p>0.05), while a significant difference (p<0.05) had been seen between the sexes in medulla diameter in the control groups. Humerus compact bone density in male rats and medulla canal diameter of female rats are significant in terms of the difference between groups (p<0.05), and gender effect on the change arising in medulla canal diameter as a result of ME administration has been revealed to be insignificant (p>0.05). It was concluded that the ME effect on rat humerus, similar to that of other AAS, consists in supressing bone growth in male animals while enhancing it in females during puberty. Rat models show negative middle-term and long-term effects of this agent, which is still widely in use as a performance enhancer, as opposed to its positive results in the short term. ©2011 Academic Journals.en_US
dc.identifier.endpage2681en_US
dc.identifier.issn1992-2248en_US
dc.identifier.issue13en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage2676en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/27261
dc.identifier.volume6en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.relation.ispartofScientific Research and Essaysen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectAdolescent ratsen_US
dc.subjectAthletesen_US
dc.subjectBoneen_US
dc.subjectMethenolone enanthateen_US
dc.subjectMorphometricen_US
dc.titleMorphometric evaluation of the effect of methenolone enanthate on humeral development in adolescent ratsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu